The Acute Coronary Syndrome Study
- Conditions
- Acute Coronary SyndromeCardiovascular - Other cardiovascular diseases
- Registration Number
- ACTRN12605000431628
- Lead Sponsor
- Z Health Research Council
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- All
- Target Recruitment
- 2000
Ischaemic discomfort plus one or more of ECG changes (ST segment depression or elevation of at least 0.5mm, T-wave inversion of at least 3mm in at least 3 leads, or left bundle branch block), elevated levels of cardiac markers, a history of coronary disease, or age of at least 65 years in patients with diabetes or vascular disease (i.e. the identical criteria as those used in the recent OPUS-TIMI 16 trial and reiterated in the recent New England Journal article by De Lemos et al on the prognostic value of B-type natriuretic peptide in patients with acute coronary syndromes [43a]). The deliberate aim is to include a broad spectrum of age, both genders and significant sub-groups with the important antecedent risk factors and disease processes such as hypertension and diabetes.
Severe co-morbidity limiting life expectancy to less than 3 years. Unable to provide written informed consent. Unable to attend for follow-up.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method